The Current Ratio as of November 2024 (TTM) for Amneal Pharmaceuticals, Inc. (AMRX) is 1.33

According to Amneal Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.33. This represents a change of -18.33% compared to the average of 1.63 of the last 4 quarters.

Amneal Pharmaceuticals, Inc. (AMRX) Historical Current Ratio (quarterly & annually)

How has AMRX Current Ratio performed in the past?

The mean historical Current Ratio of Amneal Pharmaceuticals, Inc. over the last ten years is 2.09. The current 1.33 Current Ratio has changed 6.27% with respect to the historical average. Over the past ten years (40 quarters), AMRX's Current Ratio was at its highest in in the December 2016 quarter at 3.23. The Current Ratio was at its lowest in in the March 2017 quarter at 0.

Amneal Pharmaceuticals, Inc. (AMRX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Amneal Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Amneal Pharmaceuticals, Inc. (AMRX) Average Current Ratio

How has AMRX Current Ratio performed in the past?

The current Current Ratio of Amneal Pharmaceuticals, Inc. (AMRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Amneal Pharmaceuticals, Inc. (AMRX) Current Ratio vs. Peers

How is AMRX’s Current Ratio compared to its peers?

Amneal Pharmaceuticals, Inc.’s Current Ratio is less than Alkermes plc (3.45), less than Neurocrine Biosciences, Inc. (4.37), less than Intra-Cellular Therapies, Inc. (7.66), less than Deciphera Pharmaceuticals, Inc. (4.19), less than Dynavax Technologies Corporation (14.18), less than Amphastar Pharmaceuticals, Inc. (3.52), greater than Collegium Pharmaceutical, Inc. (1.11), less than Ironwood Pharmaceuticals, Inc. (3.92), less than ANI Pharmaceuticals, Inc. (3.97), less than Phibro Animal Health Corporation (2.94), less than Procaps Group S.A. (1.47), less than Silver Spike Investment Corp. (6.09), less than Eagle Pharmaceuticals, Inc. (1.70), less than Evolus, Inc. (2.92), greater than Agile Therapeutics, Inc. (0.55), less than Assertio Holdings, Inc. (1.93), less than AcelRx Pharmaceuticals, Inc. (4.04), less than Lifecore Biomedical, Inc. (1.83),

Build a custom stock screener for Amneal Pharmaceuticals, Inc. (AMRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amneal Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Amneal Pharmaceuticals, Inc. (AMRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Amneal Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.